This cascade transforms the TIME, markedly enhancing CD8 + T cell infiltration and NK cell cytotoxicity, resulting in significant tumor burden reduction and prolonged survival in aggressive, clinically relevant murine models [133]. This evidence concerns the gene CD8A and neoplasm.